US 11365265
Anti-C5 antibody combinations and uses thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11365265 (Anti-C5 antibody combinations and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K31/573